What we do
In the Molecular Allergology group we are aiming to unravel the molecular basis of allergic diseases, antigen presentation, immunotherapies, immunotolerance and tolerance breakage with a combination of functional genomics techniques, including proteomics, peptidomics and immunopeptidomics. With proteomics we also aim at identifying cellular proteotypes associated with immune system regulation, and to identify allergens in various food samples. The acquired large-scale molecular data are analysed with the aim to identify molecular markers with which risk factors, different disease phenotypes, their underlying pathogenic mechanisms, and different patient response groups can be distinguished.
Find out about the Group’s activities
Main publication 2021
- Bates A E et al.
Global COVID-19 lockdown highlights humans as both threats and custodians of the environment
Biological conservation, 10.1016/j.biocon.2021.109175 - Kern U et al.
Impact of DJ-1 and Helix 8 on the Proteome and Degradome of Neuron-Like Cells
Cells, 10.3390/cells10020404 - Ogulur I et al.
Advances and highlights in biomarkers of allergic diseases
Allergy, 10.1111/all.15089
